Salindawan, Abdul Razzaq D.

HRN: 21-72-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
AMPICILLIN 500MG (VIAL)
09/11/2023
09/17/2023
IV
250mg
Q6h
URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: